secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2021-10-01T23:59:59+00:00
Accession:  0001193125-21-289829
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma enters $80M at-the-market equity offering agreement with Jefferies
--------------------------------------------------------------------------------

- Company enters Open Market Sale Agreement with Jefferies LLC to sell up to $80M of common stock at-the-market.
- Prior $40M ATM agreement with Stifel terminated; $33.4M in gross proceeds realized from 2,099,700 shares sold.
- Jefferies will receive 3.0% commission on gross proceeds from sales under the new agreement.
- Shares will be sold under existing shelf registration statement; prospectus supplement filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000119312521289829/0001193125-21-289829-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000119312521289829/d197369d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-289829

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer